We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $72.6B
1-Year Est. Return 54.88%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+12.02%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$64.6B
AUM Growth
+$5.95B
Cap. Flow
+$299M
Cap. Flow %
0.46%
Top 10 Hldgs %
11.91%
Holding
4,318
New
702
Increased
1,590
Reduced
1,355
Closed
633

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$653M
2
AMZN icon
Amazon
AMZN
+$602M
3
XOM icon
ExxonMobil
XOM
+$473M
4
TSLA icon
Tesla
TSLA
+$437M
5
SBUX icon
Starbucks
SBUX
+$380M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Healthcare 17.69%
3 Consumer Discretionary 13.09%
4 Industrials 7.96%
5 Consumer Staples 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CATC
2651
DELISTED
CAMBRIDGE BANCORP
CATC
$655K ﹤0.01%
9,441
-2,480
-21% -$151K
CGNX icon
2652
Cognex
CGNX
$11B
$653K ﹤0.01%
15,656
-194,900
-93% -$7.49M
PLBC icon
2653
Plumas Bancorp
PLBC
$439M
$653K ﹤0.01%
15,801
+7,801
+98% +$281K
TUR icon
2654
iShares MSCI Turkey ETF
TUR
$222M
$652K ﹤0.01%
20,200
-20,600
-50% -$727K
NGM
2655
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$650K ﹤0.01%
756,892
+234,565
+45% +$206K
NN icon
2656
NextNav
NN
$3.36B
$647K ﹤0.01%
+145,400
New +$657K
MLNK
2657
DELISTED
MeridianLink
MLNK
$646K ﹤0.01%
26,100
+15,600
+149% +$303K
LONA
2658
LeonaBio Inc
LONA
$74.8M
$645K ﹤0.01%
26,540
-1,750
-6% -$31K
CMTG icon
2659
Claros Mortgage Trust
CMTG
$257M
$645K ﹤0.01%
47,300
-30,600
-39% -$364K
DUK icon
2660
Duke Energy
DUK
$96.6B
$645K ﹤0.01%
6,650
-33,245
-83% -$3.02M
CIA icon
2661
Citizens
CIA
$201M
$644K ﹤0.01%
239,394
-8,100
-3% -$25K
IYC icon
2662
iShares US Consumer Discretionary ETF
IYC
$1.22B
$644K ﹤0.01%
8,500
+1,800
+27% +$126K
PBI icon
2663
Pitney Bowes
PBI
$2.25B
$644K ﹤0.01%
146,471
-364,600
-71% -$1.41M
ICCC icon
2664
ImmuCell
ICCC
$90.9M
$642K ﹤0.01%
126,189
+4,809
+4% +$23.5K
SMP icon
2665
Standard Motor Products
SMP
$870M
$641K ﹤0.01%
+16,100
New +$574K
OKUR
2666
OnKure Therapeutics
OKUR
$162M
$641K ﹤0.01%
40,040
+36,440
+1,012% +$2.27M
RLGT icon
2667
Radiant Logistics
RLGT
$408M
$640K ﹤0.01%
96,400
-15,300
-14% -$92.7K
NIU
2668
Niu Technologies
NIU
$163M
$639K ﹤0.01%
291,600
+2,600
+0.9% +$5.95K
TUSK icon
2669
Mammoth Energy Services
TUSK
$160M
$638K ﹤0.01%
142,972
-9,600
-6% -$42.6K
AWR icon
2670
American States Water
AWR
$3.53B
$635K ﹤0.01%
7,900
-2,700
-25% -$216K
DRCT icon
2671
Direct Digital Holdings
DRCT
$1.95M
$633K ﹤0.01%
193
+8
+4% +$11.8K
NGVT icon
2672
Ingevity
NGVT
$2.64B
$633K ﹤0.01%
+13,400
New +$557K
PEBK icon
2673
Peoples Bancorp of North Carolina
PEBK
$239M
$632K ﹤0.01%
20,412
-1,300
-6% -$32.8K
FENY icon
2674
Fidelity MSCI Energy Index ETF
FENY
$2.09B
$631K ﹤0.01%
27,400
-800
-3% -$18.8K
HNNA icon
2675
Hennessy Advisors
HNNA
$79.3M
$631K ﹤0.01%
94,022
+7,547
+9% +$49.6K

Similar funds

Jim Simons's Q4 2023 Portfolio in Review

As of Q4 2023, Jim Simons held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Jim Simons's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Jim Simons's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
  • Jim Simons added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
  • Jim Simons's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
  • Jim Simons fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
  • Jim Simons's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
  • Jim Simons opened 702 new positions and closed 633 in Q4 2023.
  • Jim Simons's portfolio value rose 10% quarter-over-quarter to $64.6B.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.